Xtant Medical Holdings (XTNT) Revenue (2010 - 2025)

Xtant Medical Holdings (XTNT) has reported Revenue for 16 consecutive years, with $33.3 million the latest figure, recorded in Q3 2025.

• On a quarterly basis, Revenue rose 19.04% year-over-year to $33.3 million in Q3 2025; TTM through Sep 2025 was $133.1 million, a 16.88% increase from a year earlier, with the FY2024 full-year figure at $117.3 million, up 28.44% from the prior year.
• Revenue was $33.3 million for Q3 2025 at Xtant Medical Holdings, down from $35.4 million in the prior quarter.
• Over five years, Revenue peaked at $35.4 million in Q2 2025 and troughed at $12.5 million in Q1 2021.
• A 5-year average of $22.3 million and a median of $20.2 million in 2023 frame the typical range for Revenue.
• Across the five-year window, Revenue slipped 15.13% in 2021 and surged 84.07% in 2023, its largest moves.
• Over 5 years, Revenue stood at $14.0 million in 2021, then grew by 9.31% to $15.3 million in 2022, then jumped by 84.07% to $28.1 million in 2023, then advanced by 12.11% to $31.5 million in 2024, then gained by 5.53% to $33.3 million in 2025.
• The last three Revenue figures came in at $33.3 million (Q3 2025), $35.4 million (Q2 2025), and $32.9 million (Q1 2025), per Business Quant data.